Changes in cytokines and neurotrophins in Parkinson’s disease (original) (raw)
References
Anglade P, Vyas S, Javoy-Agid F, Herreto MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch C, Agid Y (1997a) Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol Histopathol 12: 25–31 CAS Google Scholar
Anglade P, Vyas S, Hirsch EC, Agid Y (1997b) Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Hisopathol 12: 603–610 CAS Google Scholar
Aubin A, Curet O, Deffois A, Carter C (1998) Aspirin and salycylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71: 1635–1642 ArticlePubMedCAS Google Scholar
Banati RB, Daniel SE, Blunt SB (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov Disord 13: 221–227 ArticlePubMedCAS Google Scholar
Blum-Degan D, Müller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin 113 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo Parkinson’s disease patients. Neurosci Lett 202: 17–20 Article Google Scholar
Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC (1994) Immunocytochemical analysis of tumor necrosis factor and its receptor in Parkinson’s disease. Neurosci Lett 172: 151–154 ArticlePubMedCAS Google Scholar
Breitner JC (1996) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer’s disease. Ann Rev Med 47: 401–411 ArticlePubMedCAS Google Scholar
Burke RE, Kholodilov NG (1998) Programmed cell death: does it play a role in Parkinson’s disease? Ann Neurol 44 Suppl 1: S126–S133 ArticlePubMedCAS Google Scholar
Caparros-Lefebvre D, Elbaz A, the Caribbean Parkinsonism Study Group (1999) Possible relation of atypical parkinsonism in the French west indies with consumption of tropical plants and case-control study. Lancet 354: 281–286 CAS Google Scholar
Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan CF (1993) Microglia and cytokines in neurological diseases, with special reference to AIDS and Alzheimer’s disease. Glia 7: 76–82 Article Google Scholar
Fan DS, Ogawa M, Ikeguchi K, Fujimoto K, Uraba M, Kume K, Nishizawa M, Matsushita N, Kiuchi K, Ichinose H, Nagatsu T, Kurzman GJ, Nakano I, Ozawa K (1996) Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro. Neurosci Lett 248: 61–64 Article Google Scholar
Foley P, Riederer P (1999) Pathogenesis and preclinical course of Parkinson’s disease. J Neural Transm Suppl 56: 31–74 ArticlePubMedCAS Google Scholar
Fujishiro K, Hagihara M, Takahashi A, Nagatsu T (1999) Concentrations of neopterin and biopterin in the cerebrospinal fluid of patients with Parkinson’s disease. Biochem Med Metab Biol 44: 97–100 Article Google Scholar
Furukawa Y, Nishi K, Kondo T, Mizuno Y, Narabayashi H (1993) CSF biopterin levels and clinical features of patients with juvenile parkinsonism. Adv Neurol 60: 562–567 PubMedCAS Google Scholar
Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russel D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252–255 ArticlePubMedCAS Google Scholar
Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K, Nagatsu T (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8: 236–242 ArticlePubMedCAS Google Scholar
Ichinose H, Suzuki T, Inagaki H, Ohye T, Nagatsu T (1999a) Molecular genetics of dopa-responsive dystonia. Biol Chem 380: 1355–1364 ArticleCAS Google Scholar
Ichinose H, Ohye T, Suzuki T, Sumi-Ichinose C, Nomura T, Hagino Y, Nagatsu T (1999b) Molecular cloning of the human Nurr 1 gene: characterization of the human gene and cDNAs. Gene 230: 233–239 ArticleCAS Google Scholar
Jelliger KA (1999) Is there apoposis in Lewy body disease? Acta Neuropathol (Berl) 97: 413–415 Article Google Scholar
Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutation in the perkin gene cause autosomal recessive juvenile parkinsonism. Nature 329: 605–608 Google Scholar
Kosel S, Egensperger R, von-Eitzen U, Mehraein P, Graeber MB (1997) On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol (Berl) 93: 105–108 ArticleCAS Google Scholar
Kotake Y, Tasaki Y, Makino Y, Ohta S, Hirobe M (1995) 1-Benzyl-1,2,3,4tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian brain. J Neurochem 65: 2633–2638 ArticlePubMedCAS Google Scholar
Levivier M, Przedborski S, Bencsics C, Kang UJ (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson’s disease. J Neurosci 15: 7810–7820 PubMedCAS Google Scholar
Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA (1998) Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer’s disease. J Neuropathol Exp Neurol 57: 1041–1052 ArticlePubMedCAS Google Scholar
Matsubara K, Kobayashi S, Kobayashi Y, Yamashita K, Koide H, Hatta M, Iwamoto K, Tanaka O, Kimura K (1995) ß-Carbolinium cations, endogenous MPP+ analogs in the lumber cerebrospinal fluid of parkinsonian patients. Neurology 45: 2240–2245 ArticlePubMedCAS Google Scholar
McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s disease and Alzheimer’s disease brains. Neurology 38: 1285–1291 ArticlePubMedCAS Google Scholar
Mochizuki H, Goto K, Mori H, Mizuno Y (1996) Histochemical detection of apoptosis in Parkinson’s disease. J Neurol Sci 137: 120–123 ArticlePubMedCAS Google Scholar
Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994a) Tumor necrosis factor-a (TNF-a) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208–210 ArticleCAS Google Scholar
Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994b) Interleukin-1ß, interleukin-6, epidermal growth factor and transforming growth factor-a are elevated in the brain from parkinsonian patients. Neurosci Lett 180: 147–150 ArticleCAS Google Scholar
Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T (1995a) Transforming growth factor-ß1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson’s disease. Neurosci Lett 193: 129–132 ArticleCAS Google Scholar
Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T (1995b) Brain 132-microglobulin are elevated in the striatum in Parkinson’s disease. J Neural Transm [P-D Sect] 9: 87–92 ArticleCAS Google Scholar
Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T (1996a) Interleukin (IL)-113, IL-2, IL-4, IL-6 and transforming growth factor-a levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson’s disease. Neurosci Lett 211: 13–16 ArticleCAS Google Scholar
Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P, Nagatsu T (1996b) bc1–2 Protein is increased in the brain from parkinsonian patients. Neurosci Lett 215: 1–2 CAS Google Scholar
Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T (1996c) Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. J Neural Transm 103: 1077–1081 ArticleCAS Google Scholar
Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P, Nagatsu T (1996d) The soluble form of Fas molecule is elevated in parkinsonian brain tissues. Neurosci Lett 220: 195–198 ArticleCAS Google Scholar
Mogi M, Togari A, Ogawa M, Ikeguchi K, Shizuma N, Fan D-S, Nakano I, Nagatsu T (1998) Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP) to mice on interleukin-113 and nerve growth factor in the striatum. Neurosci Lett 250: 25–28 ArticlePubMedCAS Google Scholar
Mogi M, Togari A, Tanaka K, Ogawa N, Ichinose H, Nagatsu T (1999a) Increase in level of tumor necrosis factor (TNF)-a in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-a induction. Neurosci Lett 268: 101–104 ArticleCAS Google Scholar
Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T (1999b) Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson’s disease. Neurosci Lett 270: 45–48 ArticleCAS Google Scholar
Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T (2000) Caspase activities and tumor necrosis factor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain. J Neural Transm 107: 335–341 ArticlePubMedCAS Google Scholar
Nagatsu T (1991) Genes for human catecholamine-synthesizing enzymes. Neurosci Res 12: 315–345 ArticlePubMedCAS Google Scholar
Nagatsu T (1993) Biochemical aspects of Parkinson’s disease. Adv Neurol 60: 165–174 PubMedCAS Google Scholar
Nagatsu T, Mogi M, Ichinose H, Togari A, Riederer P (1999) Cytokines in Parkinson’s disease. NeuroSci News 2: 88–90 CAS Google Scholar
Naoi M, Maruyama Y, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M (1996) Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rats: biochemcal, pathological and behavioral studies. Brain Res 707: 285–295 Article Google Scholar
Naoi M, Maruyama W, Kasamatsu T, Dostert P (1998) Oxidation of Nmethyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines. J Neural Transm Suppl 52: 125–138 ArticlePubMedCAS Google Scholar
Olanow CW, Kordower JH, Freeman TB (1996) Fetal nigral transplantation as a therapy for Parkinson’s disease. Trends Neurosci 19: 102–109 ArticlePubMedCAS Google Scholar
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Sternroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, brio GD, Golie LI, Nussbaum RL (1997) Mutation of the a-synuclein gene identified in families with Parkinson’s disease. Science 276: 2045–2047 ArticlePubMedCAS Google Scholar
Sacco J, Agnello D, Sottocorno M, Lozza G, Monopoll A, Vilia P, Ghezzl P (1998) Nonsteroidal anti-inflammatory drugs increase tumor necrosis factor production in the periphery but not in the central nervous system in mice and rats. J Neurochem 71: 2063–2070 ArticlePubMedCAS Google Scholar
Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H (1976) Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 14: 215–233 PubMedCAS Google Scholar
Snyder SH, Lai MM, Burnett PE (1998) Immunophilins in the nervous system. Neuron 21: 283–294 ArticlePubMedCAS Google Scholar
Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and Nmethylpyridinium ion activity: involvement of the glutathione system. J Neurochem 59: 99–106 ArticlePubMedCAS Google Scholar
Stadtmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 57: 456–464 Article Google Scholar
Stern G (1996) Parkinson’s disease: the apoptosis hypothesis. Adv Neurol 69: 101–107 Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer’s disease and duration of NSAID use. Neurology 48: 101–107 Google Scholar
Takahashi H, Levine RA, Galloway MP, Snow BJ, Calne DB, Nygaard TG (1994) Biochemical and fluorodopa positron emmision tomograph findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann Neurol 35: 354–356 ArticlePubMedCAS Google Scholar
Tatton NA, Maclean-Fraser A, Tatton WG, Perl DP, Olanow CW (1998) A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson’s disease. Ann Neurol 44 Suppl 1: S142–S148 Google Scholar
Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ (1996) TGFßl and TGF132 concentrations are elevated in Parkinson’s disease in ventricular cerebrospinal fluid. Exp Neurol 142: 313–322 ArticlePubMedCAS Google Scholar
Wullner U, Kornhuber J, Weller M, Schulz JB, Loschmann PA, Riederer P, Klockgether T (1999) Cell death and apoptosis regulating proteins in Parkinson’s disease¡ªa cautionary note. Acta Neuropathol (Berl) 97: 408–412 ArticleCAS Google Scholar
Yurek DM, Lu W, Hipkens S, Wiegand SJ (1996) BDNF enhances the functional reinner-vation of the striatum by grafted fetal DA neurons. Exp Neurol 137: 105–118 ArticlePubMedCAS Google Scholar